許 志新

Medicine & Life Sciences

1. Pulmonary Arterial Hypertension 100%
2. Pulmonary Hypertension 88%
3. Pulmonary Embolism 35%
4. Pulmonary Artery 31%
5. Mortality 29%
6. Right Ventricular Dysfunction 27%
7. Echocardiography 27%
8. Lung 23%
9. riociguat 19%
10. Cardiology 18%
11. Registries 17%
12. Endocarditis 17%
13. MicroRNAs 16%
14. Systolic Heart Failure 16%
15. Thrombosis 15%
16. Rosuvastatin Calcium 15%
17. Heart Arrest 15%
18. Fistula 15%
19. Connective Tissue Diseases 15%
20. Cardiopulmonary Resuscitation 15%
21. Extracorporeal Membrane Oxygenation 14%
22. Cohort Studies 14%
23. Hospitalization 13%
24. Arteriovenous Fistula 12%
25. Myocarditis 12%
26. Right Ventricular Function 12%
27. Exercise 12%
28. Guidelines 11%
29. Therapeutics 11%
30. Survival 10%
31. Brain Natriuretic Peptide 10%
32. Pressure 9%
33. Blood Pressure 9%
34. Schizophyllum 9%
35. Phosphodiesterase 5 Inhibitors 9%
36. Familial dilated cardiomyopathy 9%
37. Endothelial Progenitor Cells 9%
38. Embolectomy 9%
39. Neurological Models 9%
40. Desmoplakins 8%
41. Ventricular Remodeling 8%
42. Chylous Ascites 8%
43. Growth Differentiation Factor 15 8%
44. Hemodynamics 8%
45. Transplantation 8%